NVS Novartis AG

$137.16▼ -0.23% Healthcare Other
After hours $137.26▲ +0.07% Sep 11, 6:55 PM ET
Volume 2.35M Avg Volume (10D) 3.17M
Key Metrics & Fundamentals
Market Cap
$260.70B
P/E Ratio
20.7
Div Yield
3.45%
52W Range
121.57 - 170.46
% vs 50 MA
-11.02%
% vs 200 MA
-8.52%
RSI-14
31.5
MACD Histogram
-2.5700
Beta (1Y vs SPY)
0.35
Free Cash Flow
$5.12B
Gross Rev
$14.95B
Gross Profit
$11.24B
EBITDA
$6.13B
COGS
$3.71B
Operating Exp
$6.49B
Operating Income
$4.75B
EBIT
$4.75B
Pretax Income
$4.27B
Net Income
$3.26B
EPS (Diluted)
1.71
Price & Volume History
Loading chart…
Recent News
Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
Insider Monkey · Sep 12, 2026 10:48 AM
Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness
The Wall Street Journal · Sep 12, 2026 9:30 AM
Novartis: More Pain on the Way?
Barrons.com · Sep 11, 2026 10:42 PM
Jim Cramer Says He Is Not Going to Put His Money on AstraZeneca (AZN)
Insider Monkey · Sep 11, 2026 8:02 PM
Novartis's $30 Billion Deal Spree Triggers a Boardroom Reckoning
GuruFocus.com · Sep 11, 2026 7:54 PM
MLTX Stock On Track For Worst Week Since Last Fall As FDA Filing Date For Skin Disease Drug Draws Near
Stocktwits · Sep 11, 2026 5:48 PM
Health Care Roundup: Market Talk
The Wall Street Journal · Sep 11, 2026 4:30 PM
Amgen Drops 10% on a Trial It Didn't Even Run
MarketBeat · Sep 11, 2026 4:05 PM
Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s
Zacks · Sep 11, 2026 3:26 PM
Drug Trial Setbacks Raise Questions Over Novartis (NVS)’s Growth Pipeline
Insider Monkey · Sep 11, 2026 3:10 PM
Financial Overview - Income Statement Quarterly

See NVS's money flow as a full page

Social Sentiment
Avg -0.05 · 2 posts
TradeDiscussionNewsDDNVS to acquire a company and turned it no longer into a penny stock
r/wallstreetbets · Apr 30, 2025
Strong bullish sentiment expressed due to successful acquisition and personal financial gains.
positive +0.80
DiscussionNewsVolatility in Pharma, similar to tech but reason not clear.
r/wallstreetbets · Jul 18, 2024
The author uses strong language ('losing their ass') to describe NVS’s performance.
negative -0.90
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙